Payment overview · 2025
General Payments
$25.98
1 reported records · 1 companies
Healthcare provider profile · identity verified
Emily Schmitter
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner · GAHANNA, OH · NPI 1942930839
Verified facts
What the public records show
CMS Open Payments records show Emily Schmitter received $25.98 in general payments during 2025 across 1 reported records.
ABBVIE INC. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| ABBVIE INC. | Unresolved — no canonical attribution shown | $25.98 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $25.98 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| QULIPTA Normalized: qulipta |
Drug | ABBVIE INC. | $25.98 | 1 | 2025 |
Source payment records
|
|||||
| UBRELVY Normalized: ubrelvy |
Drug | ABBVIE INC. | $25.98 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 629 | 75 |
| Sertraline Hcl | Sertraline Hcl | 532 | 71 |
| Levothyroxine Sodium | Levothyroxine Sodium | 520 | 63 |
| Omeprazole | Omeprazole | 393 | 52 |
| Amlodipine Besylate | Amlodipine Besylate | 328 | 54 |
| Gabapentin | Gabapentin | 321 | 41 |
| Lisinopril | Lisinopril | 314 | 36 |
| Furosemide | Furosemide | 313 | 57 |
| Losartan Potassium | Losartan Potassium | 288 | 40 |
| Trazodone Hcl | Trazodone Hcl | 284 | 40 |
| Donepezil Hcl | Donepezil Hcl | 280 | 35 |
| Mirtazapine | Mirtazapine | 270 | 36 |
| Memantine Hcl | Memantine Hcl | 261 | 39 |
| Metoprolol Succinate | Metoprolol Succinate | 258 | 45 |
| Tamsulosin Hcl | Tamsulosin Hcl | 251 | 31 |
| Potassium Chloride | Potassium Chloride | 207 | 39 |
| Eliquis | Apixaban | 206 | 30 |
| Quetiapine Fumarate | Quetiapine Fumarate | 197 | 32 |
| Escitalopram Oxalate | Escitalopram Oxalate | 194 | 27 |
| Pantoprazole Sodium | Pantoprazole Sodium | 194 | 30 |
| Metoprolol Tartrate | Metoprolol Tartrate | 191 | 28 |
| Hydrochlorothiazide | Hydrochlorothiazide | 180 | 19 |
| Divalproex Sodium | Divalproex Sodium | 175 | 22 |
| Metformin Hcl | Metformin Hcl | 155 | 22 |
| Buspirone Hcl | Buspirone Hcl | 142 | 26 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 133 | 16 |
| Carvedilol | Carvedilol | 127 | 21 |
| Allopurinol | Allopurinol | 108 | suppressed |
| Duloxetine Hcl | Duloxetine Hcl | 108 | 14 |
| Olanzapine | Olanzapine | 106 | 17 |
| Clopidogrel | Clopidogrel Bisulfate | 103 | 18 |
| Alendronate Sodium | Alendronate Sodium | 100 | 16 |
| Citalopram Hbr | Citalopram Hydrobromide | 98 | 16 |
| Finasteride | Finasteride | 93 | 12 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 93 | 14 |
| Tramadol Hcl | Tramadol Hcl | 90 | 33 |
| Warfarin Sodium | Warfarin Sodium | 87 | suppressed |
| Loperamide | Loperamide Hcl | 86 | 31 |
| Simvastatin | Simvastatin | 80 | suppressed |
| Galantamine Hbr | Galantamine Hbr | 79 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 77 | 15 |
| Glimepiride | Glimepiride | 74 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 71 | suppressed |
| Pregabalin | Pregabalin | 69 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 64 | suppressed |
| Famotidine | Famotidine | 60 | suppressed |
| Januvia | Sitagliptin Phosphate | 60 | suppressed |
| Nuplazid | Pimavanserin Tartrate | 59 | suppressed |
| Atenolol | Atenolol | 56 | suppressed |
| Lovastatin | Lovastatin | 56 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 56 | suppressed |
| Spironolactone | Spironolactone | 54 | 12 |
| Glipizide | Glipizide | 53 | suppressed |
| Lorazepam | Lorazepam | 53 | 17 |
| Sucralfate | Sucralfate | 50 | suppressed |
| Bupropion Xl | Bupropion Hcl | 49 | suppressed |
| Levetiracetam | Levetiracetam | 47 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 46 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 44 | 22 |
| Amiodarone Hcl | Amiodarone Hcl | 44 | suppressed |
| Latanoprost | Latanoprost | 44 | suppressed |
| Meloxicam | Meloxicam | 44 | suppressed |
| Baclofen | Baclofen | 42 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 41 | suppressed |
| Xarelto | Rivaroxaban | 41 | suppressed |
| Cephalexin | Cephalexin | 40 | 21 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 39 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 38 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 37 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 34 | suppressed |
| Prednisone | Prednisone | 34 | suppressed |
| Lamotrigine | Lamotrigine | 33 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 33 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 33 | 20 |
| Valsartan | Valsartan | 33 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 32 | suppressed |
| Nifedipine Er | Nifedipine | 31 | suppressed |
| Aripiprazole | Aripiprazole | 30 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 30 | 12 |
| Methenamine Hippurate | Methenamine Hippurate | 30 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 30 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 30 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 29 | suppressed |
| Myrbetriq | Mirabegron | 29 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 28 | suppressed |
| Nystatin | Nystatin | 27 | 12 |
| Propranolol Hcl | Propranolol Hcl | 27 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 26 | 21 |
| Donepezil Hcl Odt | Donepezil Hcl | 26 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 26 | suppressed |
| Aspirin-Dipyridamole Er | Aspirin/Dipyridamole | 25 | suppressed |
| Azathioprine | Azathioprine | 25 | suppressed |
| Ezetimibe | Ezetimibe | 24 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 24 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 23 | 21 |
| Ondansetron Hcl | Ondansetron Hcl | 23 | 20 |
| Risperidone | Risperidone | 23 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 22 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 22 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 21 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 21 | suppressed |
| Gemtesa | Vibegron | 21 | suppressed |
| Nystop | Nystatin | 21 | suppressed |
| Timolol Maleate | Timolol Maleate | 21 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 20 | suppressed |
| Folic Acid | Folic Acid | 20 | suppressed |
| Cimetidine | Cimetidine | 19 | suppressed |
| Clonazepam | Clonazepam | 19 | suppressed |
| Vilazodone Hcl | Vilazodone Hcl | 19 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 18 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 18 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 17 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 17 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 16 | suppressed |
| Levofloxacin | Levofloxacin | 16 | 12 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 16 | 12 |
| Acyclovir | Acyclovir | 15 | suppressed |
| Nadolol | Nadolol | 15 | suppressed |
| Rivastigmine | Rivastigmine | 15 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 15 | suppressed |
| Advair Hfa | Fluticasone Propion/Salmeterol | 14 | suppressed |
| Carbamazepine Er | Carbamazepine | 14 | suppressed |
| Flecainide Acetate | Flecainide Acetate | 14 | suppressed |
| Nyamyc | Nystatin | 14 | suppressed |
| Colestipol Hcl | Colestipol Hcl | 13 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 13 | suppressed |
| Hydrocortisone | Hydrocortisone | 13 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 13 | suppressed |
| Sotalol | Sotalol Hcl | 13 | suppressed |
| Biktarvy | Bictegrav/Emtricit/Tenofov Ala | 12 | suppressed |
| Colchicine | Colchicine | 12 | suppressed |
| Fenofibrate | Fenofibrate | 12 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 12 | suppressed |
| Leflunomide | Leflunomide | 12 | suppressed |
| Paliperidone Er | Paliperidone | 12 | suppressed |
| Progesterone | Progesterone, Micronized | 12 | suppressed |
| Rivastigmine | Rivastigmine Tartrate | 12 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 12 | suppressed |
| Trulicity | Dulaglutide | 12 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 12 | suppressed |
| Alprazolam | Alprazolam | 11 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 11 | suppressed |
| Bethanechol Chloride | Bethanechol Chloride | 11 | suppressed |
| Fluvoxamine Maleate | Fluvoxamine Maleate | 11 | suppressed |
| Imipramine Hcl | Imipramine Hcl | 11 | suppressed |
| Jardiance | Empagliflozin | 11 | suppressed |
| Namzaric | Memantine Hcl/Donepezil Hcl | 11 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 11 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 11 | suppressed |
| Primidone | Primidone | 11 | suppressed |
| Rabeprazole Sodium | Rabeprazole Sodium | 11 | suppressed |
| Zafirlukast | Zafirlukast | 11 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $25.98 · 1 records | ABBVIE INC. | QULIPTA, UBRELVY | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error